NCT04343404View on ClinicalTrials.gov

Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

April 15, 2020

Study Completion Date

April 15, 2020

Conditions
Respiratory Distress Syndrome
Trial Locations (1)

67091

Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT04343404 - Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19 | Biotech Hunter | Biotech Hunter